Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

A metabolic vulnerability of pancreatic cancer

Unusual metabolic pathways used by cancer cells offer possible targets for the development of clinical treatments. One such pathway, involving molecules called polyamines, has been found for pancreatic cancer.
  1. Daniel J. Puleston

    1. Daniel J. Puleston is at the Precision Immunology Institute and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Icahn School of Medicine, Mount Sinai, New York, New York 10029, USA.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Does pancreatic cancer have metabolic vulnerabilities that might offer therapeutic opportunities? Writing in Nature, Lee et al.1 identify a pathway of interest.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 616, 257-258 (2023)

doi: https://doi.org/10.1038/d41586-023-00848-x

References

  1. Lee, M.-S. et al. Nature 616, 339–347 (2023).

    Article  Google Scholar 

  2. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. CA Cancer J. Clin. 71, 7–33 (2021).

    Article  PubMed  Google Scholar 

  3. Rawla, P., Sunkara, T. & Gaduputi, V. World J. Oncol. 10, 10–27 (2019).

    Article  PubMed  Google Scholar 

  4. Wang, S. et al. Signal Transduct. Target. Ther. 6, 249 (2021).

    Article  PubMed  Google Scholar 

  5. Nakkina, S. P. et al. Cancers 13, 6391 (2021).

    Article  PubMed  Google Scholar 

  6. Sari, I. N. et al. Cancer Lett. 519, 91–104 (2021).

    Article  PubMed  Google Scholar 

  7. Casero, R. A., Stewart, T. M. & Pegg, A. E. Nature Rev. Cancer 18, 681–695 (2018).

    Article  PubMed  Google Scholar 

  8. Pegg, A. E. Cancer Res. 48, 759–774 (1988).

    PubMed  Google Scholar 

  9. Holbert, C. E., Cullen, M. T., Casero, R. A. & Stewart, T. M. Nature Rev. Cancer 22, 467–480 (2022).

    Article  PubMed  Google Scholar 

  10. Roy, U. K. B., Rial, N. S., Kachel, K. L. & Gerner, E. W. Mol. Carcinogen. 47, 538–553 (2008).

    Article  Google Scholar 

  11. Ignatenko, N. A., Babbar, N., Mehta, D., Casero, R. A. & Gerner, E. W. Mol. Carcinogen. 39, 91–102 (2004).

    Article  Google Scholar 

  12. Puleston, D. J. et al. Cell 184, 4186–4202.e20 (2021).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

The author declares no competing interests.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links